Skip to content

Comparing the gum status of diabetes patients with or without laser treatment

Comparative evaluation of periodontal status of periodontits with type-2 diabetes mellitus patients after scaling and root planing with or without photobiomodulation - A split-mouth randomised clinical trial - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087900
Enrollment
20
Registered
2025-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: SCALING AND ROOT PLANING WITH PHOTOBIOMODULATION: In this study, data collection will be carried out through proper history taking of the participants in Phase 1, while in Phase 2, a de

Sponsors

Gayatri Tripathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Systemically healthy patient (Type 2 DM). 2.Pocket depths greater than or equal to 5mm measured with UNC 15 probe. 3.Clinical attachment loss greater than or equal to 4mm measured with UNC 15 probe. 4.Patients with Type 2 Diabetes Mellitus classified based on criteria of American Diabetic Association (ADA) and glycated haemoglobin levels (HbA1C) and not having systemic complications of diabetes. 5.No history of periodontal therapy in the preceding 1 year. 6.No use of antibiotics or long-term anti-inflammatory drugs in the preceding 6months

Exclusion criteria

Exclusion criteria: 1.With known systemic disease (other than type 2 diabetes) 2.Individuals with localised infection other than periodontitis. 3.Use of tobacco in any form and alcohol 4.Immunocompromised individuals 5.Pregnant or lactating females 6.Tooth with hopeless prognosis

Design outcomes

Primary

MeasureTime frame
Change in Probing pocket depth, Relative Clinical attachment level, change in gingival index, Plaque index and glycaemic health statusTimepoint: Baseline, 1 month, 3 months, 6 months

Secondary

MeasureTime frame
IL-1ß levels in GCFTimepoint: Baseline to 6 months

Countries

India

Contacts

Public ContactGayatri Tripathy

SCB Dental College and Hospital

drsubash007@gmail.com9437008298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026